References The Use of Opioids for Chronic Non-Cancer Pain While - PDF document

References The Use of Opioids for Chronic Non-Cancer Pain While Preventing Abuse and Diversion ASPMN National Conference, September 2016. 1. American Society of Addiction Medicine, (2012). Public policy statement on measures to counteract prescription drug diversion, misuse and addiction. Retrieved from https://www.asam.org/docs/public-policy-statements. 2. Atluri,S., Sudarshan,G., Manchikanti.L. ( 2014). Assessment of the trends in medical use and misuse of opioid analgesics from 2004to 2011. Pain Physician. 17; E119-E128. Retrieved from www.painphysicianjournal.com 3. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from http://www.samhsa.gov/data/ 4. Centers for Disease Control and Prevention (2015). NCHS Data ln drug poisoning deaths. Retrieved from http://www.cdc.gov/nchs/data/factsheets/factsheet_drug_poisoning.htm 5. Centers for Disease Control and Prevention Vital Signs ( 2013). Prescription painkiller overdoses. Retrieved from http://ww.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/index.html 6. Centers for Disease Control and Prevention Vital Signs ( 2015). Today’s heroin epidemic. Retrieved from www.cdc.gov/vitalsigns/pdf/2015-07-vitalsigns.pdf 7. Centers for Disease Control and Prevention. (2015). Understanding the epidemic;prescription drug overdose; cdc injury center. Retrieved from http://www.cdc.gov/drugoverdose/epidemic/ 8. Coben,J.H., Davis,S.M., Furbee,P.M., Sikora,R.,D., Tillotson,R.D. & Bossarte,R.M. (2010). Hospitalizations for poisoning by prescription opioid, sedative and tranquilizers. American Journal of Preventive Medicine; 38(5), 517-24. 9. Chou,R., Fanciullos, G.J., Fine,P.G., Adler,J.A.,Ballantyne,J.C., Davies, P., Donovan,M.I. …..Miaskowski,C. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain, 10 (2), p113-130 10. Chou,R., Turner,J., Devine,E., Hansen, R., Sullivan,S.,Blazina,I….Deyo,R. (2015). The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Annals of Internal Medicine. Retrieved from http:// annals.org 11. Cicero,T.J., Ellis,M.S., Surratt,H.L., Kurta,S.P. ( 2014). The changing face of heroin use in the United States; a restrospective analysis of the past 50 years. The Journal of American Medical Association Psychiatry. 71(7): 821-826. 12. Cook, L. (2015). The heroin epidemic in 9 graphs. US News. Retrieved at www.usnews.com/news. 13. Dart,R.C., Surratt,H.L., Cicero,T.J., Parrino, M.W., Severtson,S.G., Bucher-Bartelson,B.,, & Green,J.L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241-248. 14. Dasgupta,N., Funk,M.J., Proescholdbell,S., Hirsch,A., Ribisi,K., Marshall,S. (2016). Cohort studyof the impact of high-dose opioid analgesics on overdose mortality. Pain Medicine, 17(1); 85-98. 15. Dunn,K.M., Saunders, K.w., Rutter,C.M., Banta-Green,C.J., Merrill,J.O., Sullivan,M.D….VonKorff, M. ( 2010). Opioid Prescriptions for chronic pain and overdose. Annals of Internal Medicine; 152; 85-92. 16. Fishbain,D.A., Cole,B, Lewis,J., Rosomoff,H.L., Rosomoff,R.S. (2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop

abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Medicine 9(4), 444-459. 17. French, D.D., Chirikos, T.N., Spehar, A., Campbell, R., Means, H., Bulat, T. (2005). Effect of Concomitant Use of Benzodiazepines and Other Drugs on the Risk of Injury in a Veterans Population. Drug Safety, 28 (12), 1141-1150. 18. Frenk, S.M., Porter, K.S., & Paulozzi, L.J. (2015). Prescription opioid analgesic use among adults: United States, 199902012. NCHS data brief, no 189. Hyattsville, MD: National Center for Health Statistics 19. Gomes, T., Mamdani, M.M., Dhalla, I.A., Paterson, J.M., Juurlink, D.N. (2011). Opioid dose and drug-related mortality in patients with nonmalignant pain. Archives of Internal Medicine; 171(7), 686-691. Retrieved from http://archinte.jamanetwork.com/ 20. Im,J.J., Shachter,R.D., Oliva,E.M., Henderson,P.T., Paik,M.D., Trafton,J.A. (2015). Association of care practices with suicide attmepts in US veterans prescribed opioid medications for chronic pain management. Journal of General Internal Medicine. DOI:10.1007/s11606-015-3220-y 21. Morasco,B.J., Gritzner,S., Lewis,L., Oldham,R., Turk, D.C., Dobscha,S.K. (2011). Systematic review of prevalence, correlates, and treatment ourcomes for hcornic non-cancer pain in patients with comorbid substance use disorder. Pain, 152 (3), 488-497. 22. Massachusetts Department of Public Health: SBIRT Screening Toolkit June 2012 23. National Highway Traffic Safety Administration. (March 2016). Traffic Safety Facts; 2014 motor vehicle crashes:overview. NHTSAs national center for statistics and analysis. 24. National Institute on Drug Abuse. Prescription Drugs & Cold Medicines Retrieved from https://www.drugabuse.gov/drugs-abuse/prescription-drugs-cold-medicines on July 7, 2016 ( Chart on prescription rising rates 25. National Institute on Drug Abuse. Trends & Statistics Retrieved from https://www.drugabuse.gov/related-topics/trends-statistics on July 7, 2016 (Charts) 26. National Drug Early Warning System (2015). NDEWS Special Report. Fentayl and fentanyl analoges. Center for Substance Abuse Research by National Institute on Drug Abuse. 27. National Institute on Drug Abuse (2014). DrugFacts: Heroin. Retrieved from https://www.drugabuse.gov/publications/drugfacts/heroin on July 13, 2016 28. National Institute on Drug Abuse (2015). Overdose death rates. Retrieved from http://drugabuse.gov/related-topcis/trends-statistics/overse-death-rates. 29. National Institute on Drug Abuse. Trends & Statistics Retrieved from https://www.drugabuse.gov/related-topics/trends-statistics on April 28, 2016 30. Oliver P., Keen J. (2003). Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poisonings in Sheffield, UK, 1997-2000. Addiction. 2003 Feb; 98(2):191- 197. 31. Park,T.W., Saitz,R., Ganoczy.D., Ilgen,M.A., Bohnert, A. ( 2015). Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case- cohort study. The British Medical Journal, 350; H2698. 32. Paulozzi,L., Jones,C.J.,Mack,K.A., Rudd, R.A. (2011). Center for Disease Control and Prevention; Morbidity and Mortality Weekly Report; Nov 4, 2011/60(43); 1487-1492. 33. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. (2016). Increases in Drug and Opioid Overdose Deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 64(50-51):1378-82. 34. Substance abuse and mental health services administration. (2016). Testimony before the U.S. house committee on oversight and government reform, March 22, 2016. Statement of Kana Enomoto, principal deputy administrator, SAMHSA.

35. Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) 14-4742. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014 36. Stack,S. (2016). Confrontin a crisis; an open letter to america’s physicians on the opioid epidemic. May 11,2016. Retrieved from http:www.huffingtonpost.com/steven-j- stack/confronting-a-crisis-an-o_b_9911530.html. 37. The DAWN report (2011). ED visits involving the muscle relaxant carisoprodol. The Substance Abuse and Mental Health Services Administration, Drug Abuse Warning Network, October 27,2011. Retrieved from http://s3.amazonaws.com/zanran_storage/oas.samhsa.gov/ContentPages/2533950580.pdf 38. Toblin,R.L., Paulozzi,L.J., Logan,J.E., Hall, A.J., Kaplan, J.A. ( 2010). Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. Jounal of Clinical Psychiatry. 71(4); 491-496. 39. Von Korff, M., Kolodny,A., Deyo, R.A., Chou,R. (2011). Long-term opioid therapy reconsidered. Annals of Internal Medicine; 155(5), 325-328. 40. Volkow,N.D. (2014). Americas’ addiction to opioids: heroin and prescription drug abuse. National Institute on Drug Abuse. Presented to Senate Caucus on International Narcotic Control, May 14,2014. Retrieved from http;//ww.drugabuse.gov/about-nida/legislative- activities/testimony-to-congress/2016/Americas-addition-to-opioids-heroin-prescription-drug- abuse 41. Walton,G.r., Hayashi,K., Bach,P., Dong,H., Kerr,T., Ahamad,K….Wood,E. (2016). The impact of benzodiazepine use on mortality among polysubstance users in Vancouver, BC, Canada. Public Health Reports. 131 (3)/ 491-499. 42. Weimer,M.B & Chou.R. ( 2014). Research gaps on methadone harms and comparative harms: findings from a review of the evidence for an American pain society and college on problems of drug dependence clinical practice guideline. The Journal of Pain, Vol 15 (4): 366-376.